Antibody Drug Conjugate Global Market Factor Analysis 2018: Forecasted For an Enthralling Growth of 19% CAGR …

Antibody Drug Conjugate Global Market Factor Analysis 2018: Forecasted For an Enthralling Growth of 19% CAGR …

Global Antibody Drug Conjugate Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover market size, growth rate, opportunities, market Dynamics and Factor Analysis. And also cover the other information such as Antibody Drug Conjugate market trends, Top players, chapter-wise Description followed by various user perceptions and Forecast till 2023. […]

Neurocrine Biosciences Reports First Quarter 2018 Financial Results

Neurocrine Biosciences Reports First Quarter 2018 Financial Results

“We have had a tremendous start to 2018 with continued strong demand for INGREZZA, positive Phase III uterine fibroids results announced by AbbVie, and now have a well-defined path for a first half 2019 NDA for opicapone. One year into the commercial launch, INGREZZA’s positive clinical impact is clear and we will be expanding our […]

United Therapeutics to acquire rival drugmaker

United Therapeutics to acquire rival drugmaker

United Therapeutics to acquire rival drugmaker  Washington Business Journal Recon: United Therapeutics Seeks to Buy Rival SteadyMed for $216m  Regulatory Focus United Therapeutics Strikes Deal for SteadyMed  PharmaLive (press release) Full coverage Source link

Sparks sells regulatory fast pass to Jazz for $110M

Sparks sells regulatory fast pass to Jazz for $110M

Dive Brief: Spark Therapeutics has sold a priority review voucher (PRV) to Jazz Pharmaceuticals for $110 million, according to a Monday disclosure. While details were scant, Spark’s Chief Legal Officer Joseph La Barge said in a statement that his company intends to pump money from the deal back into R&D. The Philadelphia-based biotech’s pipeline is […]

9 days for Gardasil 9: China hands out landmark nod with lightning speed

9 days for Gardasil 9: China hands out landmark nod with lightning speed

That was unprecedently fast: Just nine days into its Gardasil 9 review, China’s revamped drug regulator handed Merck’s HPV vaccine a conditional green light—a new approval tool the agency is testing in its quest to speed new drugs to market. It’s a move that could further compress the living space of GlaxoSmithKline’s Cervarix, already pressed […]

Alkermes to Present Clinical Data at Upcoming American Psychiatric Association Annual Meeting

Alkermes to Present Clinical Data at Upcoming American Psychiatric Association Annual Meeting

“Alkermes is pleased to present this important research as a continuation of our commitment to developing novel medicines in areas of significant unmet medical need,” stated Craig Hopkinson, M.D., Chief Medical Officer and Senior Vice President of Medicines Development and Medical Affairs at Alkermes. “Our clinical and research programs continue to advance and we look […]

Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs

Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs

Xconomy San Diego —  After demonstrating in 2016 how its synthetic biology technology could produce new biologic drugs, San Diego’s Synthorx today revealed that its lead drug candidate is an improved version of interleukin-2, an anti-cancer drug of intense commercial interest in the 1980s. Synthorx said its improved version of interleukin-2, known as Synthorin IL-2, […]